An association of biotechnology scientists on Wednesday appealed to the Centre to approve Bt brinjal for commercial cultivation "without further delay" for the benefit of Indian farmers and consumers.
While financial institutions like banks not showing interest in investing in basic biotechnology research as they have long gestation periods, PE and VC funds too are not comfortable betting their money on research projects as they do not give an opportunity for a quick exit facility.
The joint secretary also said a high-level task force to work on frontiers of science related to vaccines and drug testing was formed on Sunday.
The foreign envoys were taken to Hyderabad over a month after the ministry of external affairs briefed over 190 heads of diplomatic missions and representatives of leading international organisations on COVID-19 related issues.
India's biotechnology industry has crossed the $1 billion mark in revenues.
'There is no emergency of a third wave that we are rushing for booster doses.'
a team led by ecologist Uma Ramakrishnan and her student Vinay Sagar from the National Centre for Biological Sciences, Bangalore, have discovered that the coat colouration and patterning which make the wild cats appear dark boil down to a single mutation
Currently, the country is using two 'made-in India' jabs -- Covishield and Covaxin -- to inoculate its billion-plus population and has administered 20 crore doses since launching the world's largest vaccination drive in mid-January. A third vaccine, Russian-made Sputnik V, has been approved by the government and is being used on a smaller scale at present.
Clinical trials, agri-biotech and bio-fuels are becoming opportunities. There are a lot of growth drivers and trigger points which, she said, will deliver in the next five years.
The company has received approval from the Drugs Controller General of India (DCGI) to market Itolizumab injection 25mg/5mL solution for emergency use in India for the treatment of cytokine release syndrome in moderate to severe acute respiratory distress syndrome (ARDS) due to COVID-19.
National Woman Bioscientist Awards: 2003
The formula for success of farm economy is very simple -- farmers should be able to produce more from the same piece of land at reduced cost while minimising risk and be connected to market to get higher realisation for their produce, points out Siraj Chaudhry.
In an interview with Nandita Datta she talks about biotechnology becoming the new buzzword and what it takes to build a successful career.
The company has set an affordable ceiling price of USD 3 (around Rs 225) per dose, it added.
The Indian biotechnology sector is poised for an exponential growth and would garner a global market share of 10 per cent in the next five years from the present one per cent.
'In case of shortage of other raw material, like filters and bags, one can try to develop another vendor. However, for chemicals as critical as adjuvants, this is not possible'
Joint Secretary in the Health Ministry Lav Agarwal claimed that India has been doing better than many other countries on the outcome ratio, which is the number of recoveries from coronavirus infection versus the number of deaths.
Shahid Jameel, recipient of Shanti Swarup Bhatnagar Prize for Science and Technology, also said that the country had already reached community transmission a long time ago.
This apart, to further increase capacities, Bharat Biotech has partnered with Indian Immunologicals (IIL) to manufacture the drug substance for Covaxin. The technology transfer process is underway and IIL has the 'capabilities and expertise' to manufacture the inactivated viral vaccines at commercial scale.
While virologists say theoretically the vaccine that works on Delta should work on the Delta Plus variant as well, more research is needed.
Med Ad News is a global pharmaceutical magazine and is regarded as one of the most respected journals in the segment.
Mukul Jain, enrolled in Life Sciences course, has been missing since January 8.
The Indian Institute of Science, Bangalore, invites applications from Indian nationals for the DBT-Postdoctoral Fellowship for pursuing research in the frontier areas of biotechnology and applied biology.
India's export revenue from biotechnology grew by 47 per cent to reach to 1.2 billion dollars in the financial year ended March 2007, a survey said.
Approximately 72% people wear inappropriate sized footwear which is associated with all kind of foot problems.
Early data from its vaccine candidate 'mRNA-1273' showed it produced protective antibodies in a group of eight healthy volunteers, Moderna said. The other closely watched COVID-19 vaccine is the one being developed by scientists at Oxford University.
Scientists associated with Indian SARS-CoV-2 Consortium on Genomics (INSACOG), the government panel that conducts research on different variants of the coronavirus, said they were surprised at noted virologist Shahid Jameel's decision to quit the group and wondered whether he was disillusioned with the government's handling of the pandemic.
As states grapple with a shortage of coronavirus vaccines, the Centre on Thursday said that over two billion doses will be made available in the country in five months between August and December, enough to vaccinate the entire population.
Today, an engineer from an average college can easily land an IT job. What about the biotech graduate, asks Rashmi Bansal?
In a statement, the PMO said three vaccines are in advanced stages of development in India, out of which two are in Phase II and one is in Phase-III. It further said Indian Scientists and research teams are collaborating and strengthening the research capacities in neighbouring countries such as Afghanistan, Bhutan, Bangladesh, Maldives, Mauritius, Nepal and Sri Lanka.
Institute of Bioinformatics and Applied Biotechnology, Bangalore, invites applications for its Post-graduate Diploma in Bioinformatics and Laboratory Course in Biotechniques programmes.
The Serum Institute of India, the largest vaccine maker in the world, has been chosen by Oxford and its partner AstraZeneca to manufacture the vaccine once it is ready. Trials results for the first two phases were published earlier this month.
Head of Epidemiology and Communicable diseases at the ICMR Dr Raman R Gangakhedkar said the apex health research body will begin a study on the effectiveness of the vaccine against coronavirus infection next week.
